Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Cooper

Showing results (101-110 of 151) with videos related to

Pageof 16
Sort By:
Journal of Immunological Methods|March 22, 2005
Biophotonic cytotoxicity assay for high-throughput screening of cytolytic killingChristine E Brown, Christine L Wright, Araceli Naranjo, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 11, 2016
Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen ReceptorHillary G Caruso, Hiroki Torikai, Ling Zhang, et al.
Experimental Dermatology|October 18, 2015
Differential T-cell subset representation in cutaneous squamous cell carcinoma arising in immunosuppressed versus immunocompetent individualsLaurence Feldmeyer, Grace Ching, Harina Vin, et al.
Blood|December 15, 2005
Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapyLisa Marie Serrano, Timothy Pfeiffer, Simon Olivares, et al.
Plos One|June 7, 2013
Manufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cellsHarjeet Singh, Matthew J Figliola, Margaret J Dawson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 12, 2014
Activation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanomaMarie-Andrée Forget, Shruti Malu, Hui Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2015
Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on MelanomaJanani Krishnamurthy, Brian A Rabinovich, Tiejuan Mi, et al.
Cancer Research|March 17, 2007
Combining adoptive cellular and immunocytokine therapies to improve treatment of B-lineage malignancyHarjeet Singh, Lisa Marie Serrano, Timothy Pfeiffer, et al.
Oncoimmunology|August 16, 2019
Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trialNiannian Ji, Neelam Mukherjee, Edwin E Morales, et al.
Scientific Reports|February 23, 2012
Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapyColleen M O'Connor, Sabina Sheppard, Cassie A Hartline, et al.
Pageof 16

Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
Journal of Immunological Methods|March 22, 2005
Biophotonic cytotoxicity assay for high-throughput screening of cytolytic killingChristine E Brown, Christine L Wright, Araceli Naranjo, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 11, 2016
Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen ReceptorHillary G Caruso, Hiroki Torikai, Ling Zhang, et al.
Experimental Dermatology|October 18, 2015
Differential T-cell subset representation in cutaneous squamous cell carcinoma arising in immunosuppressed versus immunocompetent individualsLaurence Feldmeyer, Grace Ching, Harina Vin, et al.
Blood|December 15, 2005
Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapyLisa Marie Serrano, Timothy Pfeiffer, Simon Olivares, et al.
Plos One|June 7, 2013
Manufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cellsHarjeet Singh, Matthew J Figliola, Margaret J Dawson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 12, 2014
Activation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanomaMarie-Andrée Forget, Shruti Malu, Hui Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2015
Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on MelanomaJanani Krishnamurthy, Brian A Rabinovich, Tiejuan Mi, et al.
Cancer Research|March 17, 2007
Combining adoptive cellular and immunocytokine therapies to improve treatment of B-lineage malignancyHarjeet Singh, Lisa Marie Serrano, Timothy Pfeiffer, et al.
Oncoimmunology|August 16, 2019
Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trialNiannian Ji, Neelam Mukherjee, Edwin E Morales, et al.
Scientific Reports|February 23, 2012
Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapyColleen M O'Connor, Sabina Sheppard, Cassie A Hartline, et al.
Pageof 16